Johnson & Johnson - Piacentinopersag

I Was Wrong About Johnson & Johnson: Upgrading To Hold (Rating Upgrade)

A reassessment of Johnson & Johnson's stock leads to a rating upgrade to Hold, reflecting new insights into the company's performance.

Editorial Staff about 9 hours ago

Money Fintech

Johnson & Johnson Harnesses AI and Robotics to Achieve $100 Billion Revenue Goal

Johnson & Johnson is making strides in healthcare innovation by integrating AI and robotic technologies, aiming for a substantial revenue increase.

Editorial Staff 1 day ago

World North America

Johnson & Johnson Invests $1 Billion in Firefly Bio to Boost KRAS Inhibitor Portfolio

In a significant move to enhance its oncology pipeline, Johnson & Johnson has announced the acquisition of Firefly Bio for $1 billion, focusing on KRAS inhibitors.

Editorial Staff about 1 month ago

#Johnson & Johnson

I Was Wrong About Johnson & Johnson: Upgrading To Hold (Rating Upgrade)

Johnson & Johnson Harnesses AI and Robotics to Achieve $100 Billion Revenue Goal

Johnson & Johnson Invests $1 Billion in Firefly Bio to Boost KRAS Inhibitor Portfolio